drug companies disagree. Robert Preidt of HealthDay News has more on this:Personally, I think the more we know the better, although
Changes need to be made to the U.S. Food and Drug Administration's policy regarding the confidentiality of drug safety data from clinical trials, say researchers at the Harvard School of Public Health and Brigham and Women's Hospital in Boston.
Current rules allow drug companies to keep data secret, which prevents the public from learning about dangerous side effects of drugs, the researchers said. Allowing greater public access to this data would enable outside experts to independently evaluate the data and perhaps detect risks sooner.